Open-access The relationship between congenital infections and autism spectrum disorder: a systematic review

Abstract

Objective:  The aim of this systematic review (SR) is to evaluate the relationship between congenital infections (Toxoplasmosis, Cytomegalovirus, Rubella, Herpes simplex type 1 and 2, HIV, Zika, and Syphilis) and the development of Autism Spectrum Disorder (ASD).

Data source:  The authors seek to identify loopholes in the current knowledge about this content and to understand the role of congenital infections in children's neurodevelopment. After the systematic search, 32 articles were included. Quality of articles was evaluated by the e Newcastle-Ottawa Scale (NOS).

Findings:  The data obtained were heterogeneous; the NOS varied from 4 to 9. In 19 studies, an association between congenital infection and the development of ASD and/or features of this spectrum was not observed. Furthermore, the present findings indicate that the link between congenital infections and ASD varies depending on the pathogen and there is no common causal factor among the diseases, as their mechanisms are not yet fully understood.

Conclusion:  This review highlights that there is a possible correlation between some congenital infections and the development of ASD, as is the case with CMV, Zika, Rubella and Toxoplasmosis infection. As the mechanisms are not yet fully understood, there is a need for further studies and research on this topic to bridge the existing knowledge gap regarding its mechanisms.

KEYWORDS
Congenital infection; Autism spectrum disorder; Torch group; Neurodevelopmental disorders; Prenatal infections

Introduction

Autism Spectrum Disorder (ASD) was described by Leo Kanner in 1943. According to DSM-5, ASD is a neurodevelopmental disorder in which there are persistent deficits in communication and social interaction, associated with restricted and repetitive patterns in behavior, interests, and activities [1]. Moreover, ASD encompasses a broad, heterogeneous manifestation that can be influenced by environmental and genetic factors. It is believed that the environment could be associated with prenatal and postnatal interactions, and in this review, we'll focus on this subject [2].

It is known that infection and inflammation during pregnancy can have an important impact on fetal brain development, although the mechanisms of this harm are not fully clarified. Although TORCH infections (Toxoplasma, Rubella, Cytomegalovirus, Herpes simplex, and Syphilis) pathogens are directly related to teratogenicity, emerging studies suggest their associations with a wider spectrum of lesions to fetal neurodevelopment. Over the past thirty years, more evidence has been raised, which indicates that a wide range of infections during pregnancy could lead to a higher risk of neurodevelopmental disorders, such as ASD [3].

Thus, the aim of this systematic review (SR) is to study if there is a relationship between congenital infections (Toxoplasmosis, Cytomegalovirus, Rubella, Herpes simplex type 1 and 2, HIV, Zika and Syphilis) and ASD. Above all, the authors seek to identify loopholes in the current knowledge about this content and to understand the role of congenital infections in children's development. Therefore, the authors hypothesize that environmental interaction between an infectious pathogen with a fetal organism in development, associated with a genetic susceptibility, can lead to neurodevelopmental disturbance, especially ASD.

Methods

This study is a systematic review. Hence, the following Mesh terms were used on databases from PubMED, Lilacs, and Embase, such as the following synonyms and acronyms: "Congenital Infection, Toxoplasma gondii" OR "CMV Infection, Congenital" OR "Rubella Syndrome OR "Congenital" OR "Congenital Zika Syndrome" OR "Virus, AIDS" OR "Syphilis, Congenital" AND "Autism Spectrum Disorders". The search strategy was developed by an institutional librarian, reviewed by the senior researcher (MLN) and is available as supplementary material (Supplementary Table 1 ).

Table 1
Data description of included articles.

The inclusion criteria were children up to 7 years old with a diagnosis of congenital infection and confirmed ASD; articles written in English and published between 2014 -2024, with the following designs (retrospective and prospective cohorts, longitudinal, cross-sectional, observational studies, case-control or case report). The exclusion criteria were articles in which the data presented did not allow ensuring how the diagnosis of congenital infection or ASD was based. This study was registered at PROSPERO (https://www.crd.york.ac.uk/prospero/) (ID CRD42024600301).

A total of four reviewers conducted the reading and selection of articles. The process was carried out in pairs, with each pair responsible for evaluating the inclusion and exclusion criteria. All articles retrieved from database searches were imported into Rayyan (https://rayyan.qcri.org), where duplicate articles were identified by the software and excluded after confirming titles and authors. Subsequently, the articles were screened by the four reviewers based on their title and abstract, with articles that did not address the relationship between one of the studied congenital infections and the development of ASD being excluded. After completing this stage, the reviewers performed a full-text reading of all selected studies for data extraction, which was carried out independently by the two pairs of reviewers.

The methodological quality of the included studies was assessed using the Newcastle-Ottawa Scale. Studies were classified according to their total score as follows: high quality, 7 to 9 points; moderate quality, 4 to 6 points; and low quality, 0 to 3 points. For analytical purposes, studies scoring 7 points or higher were considered to have good methodological quality, whereas studies scoring below 7 points were considered to have moderate or low methodological quality.

The extracted data were compiled into an Excel table with the following criteria: article characteristics (author identification, year of publication, journal name, DOI, title, objective, and study design) and sample characteristics (sample size, country of origin, follow-up period, and results). Discrepancies regarding the inclusion or exclusion of studies during this process were resolved through consensus discussions with a senior reviewer. To ensure the quality control of the selected articles, the Newcastle-Ottawa Scale (NOS) was applied, with scores ranging from 0 to 9, for case-control and cohort studies.

The present search yielded initially 286 articles, and after applying the inclusion criteria and performing a full-text review, 30 articles were included. To document the literature search process, the authors followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Figure 1 presents the flow diagram outlining the study selection process.

Fig. 1
PRISMA flow chart showing the process of systematic article search and selection.

Results

Table 1 summarizes the data extracted from the 30 articles included in this review. Results are presented according to the type of congenital infection. Of the included studies, 14 were case-control studies (mean NOS score = 6.7), 5 were prospective cohort studies (mean NOS score = 7.0), 7 were retrospective cohort studies (mean NOS score = 6.0), 3 were cross sectional and 1 case report.

Cytomegalovirus

A total of 10 articles addressed whether there is a relationship between ASD and Cytomegalovirus (CMV) [4,5,6,7,8,9,10,11,12,13]. One further study included CMV and toxoplasmosis patients [14]. These studies were published between 2015 and 2023. The design and quality of studies varied, and data was heterogeneous. Except for two studies that did not find a significant relationship between CMV and ASD, [13,14] the others suggested a higher prevalence of ASD in association of CMV congenital infection, some of them comparing the rates obtained to what was report regarding previous populational data [4,6,9].

Zika

Six articles studied ASD and the congenital Zika virus infection [15,16,17,18,19,20]. Two prospective and 2 retrospective cohorts, one case-control and one case report. The quality of studies varied, and data was heterogeneous.

Patients with Zika virus infection were at higher risk for developing neurodevelopmental abnormalities including ASD and its prevalence was higher than in the general population in some studies [15,16,20]. Also, more abnormalities in language, communication, fine and gross motor skills, cognitive and social-personal areas were reported [17,18]. In addition, there was a higher prevalence of male gender in the affected group [16]. Earlier exposition in pregnancy was associated with worse ASD features [17,18]. A case report supported that ASD can be a later manifestation of Zika virus infection even in children who do not have features of congenital Zika syndrome [19].

Toxoplasmosis

Six articles studied the relationship between ASD and Toxoplasmosis, which were published between 2016 and 2024, and one included mixed CMV and toxoplasmosis [14]. Six articles were case-control studies, [14,21,22,23,24,25] whose NOS scale ranged from 4 to 9, with a mean score of 7. Also, there was one cross-sectional study [26]. One case-control study found a significantly higher prevalence of IgG antibodies against T. gondii in the ASD group [25] and one cross-sectional study reported a higher prevalence of T gondii infection in ASD children compared to a comparison group (p < 0.001) [26]. However, no clear association was observed in the others [14,21,22,23,24].

Rubella

Three articles studied the relationship between ASD and Rubella [27,28,29] and were published between 2017 and 2023. A prospective cohort obtained an NOS score of 4 and a case-control of 6, while the last one was a cross-sectional study.

Patients with Congenital Rubella Syndrome had a higher risk for neurodevelopmental disability, particularly in communication and language domains [28] and children from mothers who seroconverted to rubella had a higher prevalence of an ASD outcome, however, the relationship did not achieve statistical significance [27].

In contrast, a small case-control study showed that individuals with seronegative of anti-rubella IgG may consider at risk for ASD while IgG seropositivity had a protective effect [29].

Herpes

Two articles studied the relationship between ASD and Herpes. The studies were published in 2014 and 2018. One article was a case-control study [30] (NOS = 5) and another was a prospective cohort study (NOS = 7) [31]. None of them found a significant association between congenital herpes virus infection and ASD.

Varicella

There was one article [32] that assessed whether there is a relationship between ASD and Varicella. The study was published in 2017, with a case-control design (NOS = 6). However, no significant association was identified.

Other agents

There was one prospective cohort study (NOS = 7) that assessed the neurodevelopmental outcome in children who had Central Nervous System (CNS) infection by several pathogens and after evaluating the outcome for each causing agent Enterovirus appeared as another infectious agent associated to the development of ASD [33].

No articles regarding HIV and Syphilis were identified after applying the criteria for this review.

Discussion

In this systematic review, the authors aimed to identify whether there is a relationship between congenital infections (Cytomegalovirus, Rubella, Herpes, Varicella, Zika, Toxoplasmosis, HIV, and Syphilis) and ASD. The data obtained were heterogeneous; however, 19 studies did find an association between congenital infection and the development of ASD and/or features of this spectrum. Furthermore, the present findings indicate that the link between congenital infections and ASD varies depending on the pathogen.

The majority of the studies suggest biological mechanisms of maternal immune activation, neuroinflammation, and genetic susceptibility as hypotheses that could explain a possible relationship between congenital infections and ASD. Infections during pregnancy trigger a strong maternal immune response, leading to an elevated level of pro-inflammatory cytokines that could affect the neurodevelopment of the fetus [26,33]. Epigenetic modifications were also addressed in some studies as possible mechanisms, suggesting that prenatal infections can generate long-term changes in gene expression related to synaptic function and neural connectivity. However, none of the studies were able to perfectly clarify the causality between infections and ASD, as well as the underlying mechanisms [4,5,6,7,8,9,10,11,12,15,16,17,18,19,20,24,25,26,27,28,30] Table 2 provides a summary of possible mechanisms that might explain the association of each congenital infection and the development of autism.

Table 2
Proposed pathophysiological mechanisms linking congenital infections to Autism Spectrum Disorder (ASD).

Regarding CMV infection, the majority of the studies have shown a possible association between this congenital infection and an increased risk of ASD, since they demonstrated a higher prevalence of CMV infection among children with ASD compared to a comparison group [4,5,6,7,8,9,10]. This congenital infection is known to induce a pro-inflammatory state in the fetal brain, characterized by increased levels of cytokines and chemokines, which can disrupt normal neurodevelopmental processes. The included studies suggest mechanisms such as direct injury to neural progenitor cells, disruption of neuronal migration and differentiation, and impairment of neural circuit formation during critical periods of neurodevelopment [4,9]. Furthermore, infection-induced neuroinflammation, characterized by microglial activation and increased production of pro-inflammatory cytokines, may interfere with synaptic pruning and the maturation of neural networks involved in social communication and behavior [11]. Evidence of white matter abnormalities, impaired brain connectivity, and hippocampal alterations in children with congenital CMV infection further supports the hypothesis that these structural and functional changes may contribute to ASD-related phenotypes [12,13]. Overall, current evidence supports an association with increased risk, likely mediated by interactions among infectious, immunological, and genetic susceptibility factors [5,6,7,8,10]. In a systematic review and meta-analyses, Maeyama and collaborators found a high prevalence of congenital CMV infection in ASD cases (OR 11.31, 95% CI 3.07-41.66). However, all three included studies had serious limitations [34].

The literature reviewed that addressed the relationship between congenital infection by Zika virus was more emphatic in the association, with ASD as one of the developmental disorders identified. In one study, it was suggested that the inflammatory response mediated by pro-inflammatory cytokines, triggered by ZIKV during pregnancy, may contribute to the development of neurodevelopmental disorders, such as ASD [19].

The studies that analyzed congenital Toxoplasmosis raised conflicting results, however, some studies reported a higher prevalence of toxoplasmosis infection in children with ASD [25,26]. Serological and molecular analyses suggested a positive relationship, where maternal toxoplasmosis infection was linked to mitochondrial DNA (mtDNA) and nuclear DNA (nDNA) damage, which may play a relevant role in autism development [24]. On the other hand, 2 studies suggested an inverse association, pointing out that higher maternal and neonatal IgG antibody levels were associated with a reduced risk of ASD, [23] and positive maternal IgM antibodies linked to lower odds of autism [21]. IgM secretion is one of the immune system's initial responses to protect against a pathogen, and one interpretation is that a sufficient immune response to acute maternal T. gondii infection during pregnancy may be protective against ASD risk in offspring [21]. Thus, there may be a more complex pathophysiological mechanism involved, which requires further investigations.

Findings concerning the association between congenital Rubella infection and ASD were heterogeneous [27,28,29] and maybe an explanation may be the varied methodologies used. However, there are enough pathophysiological mechanisms that might link ASD and congenital rubella infection. One of the strongest theories suggests that the Rubivirus impairs the enzyme responsible for the conversion of retinol to retinoic acid and the catabolism of retinoic acid, resulting in retinoid toxicity. This process could disrupt normal fetal development, increasing the risk of ASD. However, the study emphasizes that, with the currently available evidence, it is still not possible to determine whether ASD is part of Congenital Rubella Syndrome. Therefore, further research is essential to clarify the role of Rubella in ASD.

The scarce data obtained in this review that evaluated a possible association between Herpes virus infection and ASD did not reach statistical significance. This finding was supported by previous literature [35] and the direct relationship between Herpes virus and ASD remains uncertain.

No pieces of evidence for an association between Varicella Zoster and ASD were obtained in this review. As only one single article, [32] with a small sample size, was retrieved in this review, more studies on this subject are necessary.

Moreover, other pathogens than the TORCH group can lead to neurodevelopmental impairment and ASD, such as Enterovirus [33] and it ought to trigger research into other infectious agents also.

Data obtained in this review allowed us to conclude that there is plausible evidence of a possible association between CMV, Zika, Toxoplasmosis, and Rubella infections and the development of ASD. Considering that congenital infections can disrupt neurogenesis and ASD has a multifactorial etiology, this is not an unexpected finding. Although there is no certainty of a common causal factor among the diseases, as their pathogenic mechanisms are not yet fully understood, this review highlights the possible positive association between congenital infections and ASD development, but there is an urgent need for more detailed studies and research on this topic.

Acknowledgments

The authors would like to thank Alessandra Pinto Fagundes, from Biblioteca Central da PUCRS, for technical assistance and data collection support.

No third-party writing or editorial services were used in the preparation or submission of this manuscript. All individuals acknowledged have provided their consent to be named.

Statements and declarations
Not applicable.

Ethical approval
Not required.

Consent statements
Not applicable.

Funding statement

This work did not receive any specific financial support. MLN is a 1D researcher supported by the National Council for Scientific and Technological Development (CNPq)- Brazil, PQ 303,168/2021-8. RJKR and AWJ shared the PUCRS (BPA program) and CNPQ scholarship to develop this study.

Data availability

The data that support the findings of this study are available from the corresponding authors upon reasonable request, if this research is accepted for publication.

Supplementary materials

Supplementary material associated with this article can be found in the online version at doi:10.1016/j.jped.2026.101591.

References

  • 1 Hodges H, Fealko C, Soares N. Autism spectrum disorder: definition, epidemiology, causes, and clinical evaluation. Transl Pediatr 2020;9(Suppl 1):S55-65.
  • 2 Chaste P, Leboyer M. Autism risk factors: genes, environment, and gene-environment interactions. Dialogues Clin Neurosci 2012;14(3):281-92.
  • 3 Al-Haddad BJ, Oler E, Armistead B, Elsayed NA, Weinberger DR, Bernieret R, et al. The fetal origins of mental illness. Am J Obs Gynecol 2019;221(6):549-62.
  • 4 Engman ML, Sundin M, Miniscalco C, Westerlund J, Lewensohn-Fuchs I, Gillberg C, et al. Prenatal acquired cytomegalovirus infection should be considered in children with autism. Acta Paediatr 2015;104(8):792-5.
  • 5 Garofoli F, Lombardi G, Orcesi S, Pisoni C, Mazzucchelli I, Angelini M, et al. An Italian prospective experience on the association between congenital cytomegalovirus infection and autistic spectrum disorder. J Autism Dev Disord 2017;47(5): 1490-5.
  • 6 Gentile I, Zappulo E, Riccio MP, Binda S, Bubba L, Pellegrinelli L, et al. Prevalence of congenital cytomegalovirus infection assessed through viral genome detection in dried blood spots in children with autism spectrum disorders. In Vivo 2017;31(3): 467-73.
  • 7 Keymeulen A, De Leenheer E, Casaer A, Cossey V, Laroche S, Mahieu L, et al. Neurodevelopmental outcome in children with congenital cytomegalovirus infection: a prospective multicenter cohort study. Early Hum Dev2023;182:105777.
  • 8 Lin CH, Chou LC, Lee IC, Honget SY. Cytomegalovirus infection in infancy may increase the risk of subsequent epilepsy and autism spectrum disorder in childhood. Children 2021;8 (11):1040.
  • 9 Sakamoto A, Moriuchi H, Matsuzaki J, Motoyama K, Moriuchi M. Retrospective diagnosis of congenital cytomegalovirus infection in children with autism spectrum disorder but no other major neurologic deficit. Brain Dev 2015;37(2):200-5.
  • 10 Yang XY, Wang YY, Zhou YP, He J, Mei MJ, Zhang MN, et al. Postnatal cytomegalovirus infection may increase the susceptibility of tuberous sclerosis complex to autism spectrum disorders. Microbiol Spectr 2022;10(3):e0186421.
  • 11 Slawinski BL, Talge N, Ingersoll B, Arianna S, Glazier A, Kerver J, et al. Maternal cytomegalovirus sero-positivity and autism symptoms in children. Am J Reprod Immunol 2018;79(5): e12840.
  • 12 Natsume T, Inaba Y, Osawa Y, Fukuyama T. High incidence of hippocampal abnormalities in pediatric patients with congenital cytomegalovirus infection. Neuropediatrics 2022;53(4): 239-45.
  • 13 Inaba Y, Motobayashi M, Nishioka M, Kaneko T, Yamauchi S, Kawasaki Y, et al. Correlation between white matter lesions and intelligence quotient in patients with congenital cytomegalovirus infection. Pediatr Neurol 2016;55:52-7.
  • 14 Hassan ZR, Zekry KM, Heikal EA, Ibrahim HF, Khirala SK, Abd El-Hamid SM, et al. Toxoplasmosis and cytomegalovirus infection and their role in Egyptian autistic children. Parasitol Res 2023;122(5):1177-87.
  • 15 Guardado K, Varela-Cardoso M, Pérez-Roa VO, Morales-Romero J, Zenteno-Cuevas R, Ramos-Ligonio Á, et al. Evaluation of anomalies and neurodevelopment in children exposed to ZIKV during pregnancy. Children 2022;9(8):1216.
  • 16 Roth NM, Delgado-López C, Wiggins LD, Muñoz NN, Mulkey SB, Nieves-Ferrer L, et al. Notes from the field: autism spectrum disorder among children with laboratory evidence of prenatal Zika virus exposure—Puerto Rico, 2023. MMWR Morb Mortal Wkly Rep 2023;72(29):802-4.
  • 17 Grant R, Fléchelles O, Tressières B, Dialo M, Elenga N, Mediamolle N, et al. In utero Zika virus exposure and neurodevelopment at 24 months in toddlers normocephalic at birth: a cohort study. BMC Med 2022;20(1):1-14.
  • 18 Nielsen-Saines K, Brasil P, Kerin T, Vasconcelos Z, Gabaglia CR, Damasceno L, et al. Delayed childhood neurodevelopment and neurosensory alterations in the second year of life in a prospective cohort of ZIKV-exposed children. Nat Med 2019;25(8):1213-7.
  • 19 Santi L, Riesgo RS, Quincozes-Santos A;, Schuler-Faccini L, Tureta EF;, Rosa RL, et al. Zika virus infection associated with autism spectrum disorder: a case report. Neuroimmunomodulation 2021;28(3):136-41.
  • 20 Gazeta RE, Bertozzi AP, Dezena RC, Silva AC, Fajardo TC, Catalan DT, et al. Three-year clinical follow-up of children intrauterine exposed to Zika virus. Viruses 2021;13(3):523.
  • 21 Spann MN, Sourander A, Surcel HM, Hinkka-Yli-Salomäk S, Brown AS, et al. Prenatal toxoplasmosis antibody and childhood autism. Autism Res 2017;10(5):769-77.
  • 22 Esnafoğlu E, Demir EY, Cetinkol Y, Calgin MK, Erdil A, Erturk EY, et al. The seroprevalence of antibodies to toxoplasma gondii among children with autism. Dusunen Adam J Psychiatry Neurol Sci 2017;30(4):309-15.
  • 23 Grether JK, Ashwood P, Van de Water J, Yolken RH, Anderson MC, Torres AR, et al. Prenatal and newborn immunoglobulin levels from mother-child pairs and risk of autism spectrum disorders. Front Neurosci 2016;10:218.
  • 24 Al Malki JS, Hussien NA, Al Malki F. Maternal toxoplasmosis and the risk of childhood autism: serological and molecular small-scale studies. BMC Pediatr 2021;21:133.
  • 25 El-Sayed SH, Al-Shewy KA, Abdin EM, Hasan HM. Seroprevalence of toxoplasmosis among children with autism. Egypt J Neurol Psychiatry Neurosurg 2024;60:42.
  • 26 Hamid N, Azizy B, Hamidinejad H. Toxoplasma gondii infection and aggression in autistic children. Pediatr Infect Dis J 2022;41 (6):492-5.
  • 27 Hutton J. Developmental outcomes in children born to women with possible subclinical rubella exposures during pregnancy. J Med Virol 2023;95(2):e28517.
  • 28 Toizumi M, Nguyen GT, Motomura H, Nguyen TH, Pham E, Kaneko KI, et al. Sensory defects and developmental delay among children with congenital rubella syndrome. Sci Rep 2017;7:46483.
  • 29 Kadhim SJ, Abbas AA. Abdul-Jabbar OK. Sero-positivity rate of rubella antibodies in Iraqi autistic children. J Pharm Sci Res 2018;10(1):200-4.
  • 30 Gentile I, Zappulo E, Bonavolta R, Maresca R, Riccio MP, Buo-nomo AR, et al. Prevalence of herpes simplex virus 1 and 2 antibodies in patients with autism spectrum disorders. In Vivo (Brooklyn) 2014;28(4):667-71.
  • 31 Zappulo E, Riccio MP, Binda S, Pellegrinelli L, Pregliasco F, Buonomo AR, et al. Prevalence of HSV1/2 congenital infection assessed through genome detection on dried blood spot in individuals with autism spectrum disorders. In Vivo (Brooklyn) 2018;32(6):1571-7.
  • 32 Gentile I, Zappulo E, Riccio MP, Binda S, Limauro R, Scuccimarra G, et al. No evidence of congenital varicella zoster virus infection assessed through dried blood spot in children with autism spectrum disorders. Future Virol 2017;12(10): 563-8.
  • 33 Lin CH, Lin WD, Chou IC, Lee IC, Hong SY. Epilepsy and neurodevelopmental outcomes in children with etiologically diagnosed central nervous system infections: a retrospective cohort study. Front Neurol 2019;10:528.
  • 34 Maeyama K, Tomioka K, Nagase H, Yoshioka M, Takagi Y, Kato T, et al. Congenital cytomegalovirus infection in children with autism spectrum disorder: systematic review and meta-analysis. J Autism Dev Disord 2018;48(5):1483-91.
  • 35 Libbey JE, Sweeten TL, McMahon WM, Fujinami RS. Autistic disorder and viral infections. J Neurovirol 2005;11(1):1-10.

Editor

R. Soibelmann Procianoy

*

Corresponding author. E-mail: mlahorguenunes@gmail.com (M.L. Nunes).

Conflicts of interest

The authors declare no conflicts of interest.

Publication Dates

  • Publication in this collection
    20 Nov 2026
  • Date of issue
    2026

History

  • Received
    09 Feb 2026
  • Accepted
    06 July 2026
  • Published
    11 Aug 2026
location_on
Sociedade Brasileira de Pediatria Av. Carlos Gomes, 328 cj. 304, CEP: 90480-000 , Tel.: (+55 51) 3108-3328 - Porto Alegre - RS - Brazil
E-mail: jped2@sbp.com.br
rss_feed Stay informed of issues for this journal through your RSS reader
Go to top